Polymer-semaxanib moiety conjugates
View Patent ↗The invention relates to (among other things) polymer-semaxanib moiety conjugates and related compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits advantages over the semaxanib moiety in unconjugated form.
1. A compound encompassed by the formula:
and pharmaceutically acceptable salts thereof, wherein n is from 3 to 10.
2. A composition comprising a compound of claim 1 and a pharmaceutically acceptable excipient.
3. A composition of matter comprising a compound of claim 1 , wherein the compound is present in a dosage form.
4. The compound of claim 1 , wherein n is from 3 to 9.
5. The compound of claim 1 , wherein n is 3.
6. The compound of claim 1 , wherein n is 4.
7. The compound of claim 1 , wherein n is 5.
8. The compound of claim 1 , wherein n is 6.
9. The compound of claim 1 , wherein n is 7.
10. The compound of claim 1 , wherein n is 8.
11. The compound of claim 1 , wherein n is 9.